Joel Greenblatt's TXG Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 94,717 shares of 10x Genomics, Inc. (TXG) worth $1.54 M, representing 0.01% of the portfolio. First purchased in 2023-Q1, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in TXG, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 76,538 shares. Largest reduction occurred in Q3 2025, reducing 57,606 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's 10x Genomics (TXG) Holding Value Over Time
Track share changes against reported price movement
Quarterly 10x Genomics (TXG) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +75,785 | Add 400.30% | 94,717 | $16.31 |
| Q3 2025 | -57,606 | Reduce 75.26% | 18,932 | $11.69 |
| Q2 2025 | +76,538 | New Buy | 76,538 | $11.58 |
| Q1 2025 | -18,389 | Sold Out | 0 | $0.00 |
| Q4 2024 | +18,389 | New Buy | 18,389 | $14.36 |
| Q1 2024 | -8,686 | Sold Out | 0 | $0.00 |
| Q4 2023 | +1,667 | Add 23.75% | 8,686 | $55.96 |
| Q3 2023 | +114 | Add 1.65% | 7,019 | $41.25 |
| Q2 2023 | +1,881 | Add 37.44% | 6,905 | $55.84 |
| Q1 2023 | +5,024 | New Buy | 5,024 | $55.79 |
Joel Greenblatt's 10x Genomics Investment FAQs
Joel Greenblatt first purchased 10x Genomics, Inc. (TXG) in Q1 2023, acquiring 5,024 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held 10x Genomics, Inc. (TXG) for 10 quarters since Q1 2023.
Joel Greenblatt's largest addition to 10x Genomics, Inc. (TXG) was in Q2 2025, adding 76,538 shares worth $886,310.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 94,717 shares of 10x Genomics, Inc. (TXG), valued at approximately $1.54 M.
As of the Q4 2025 filing, 10x Genomics, Inc. (TXG) represents approximately 0.01% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in 10x Genomics, Inc. (TXG) was 94,717 shares, as reported at the end of Q4 2025.